Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study
Clinical trial NCT05901324 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05901324
- Sponsor
- National Taiwan University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2031-05-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.